期刊文献+

血管紧张素Ⅱ1型受体抑制剂对人子宫内膜癌裸鼠皮下移植瘤的实验研究 被引量:3

xperiment research of angiotensinⅡtype 1 receptor inhibitor's influence on human endometrial carcinoma transplanted tumor model in nude mice
下载PDF
导出
摘要 目的探讨血管紧张素Ⅱ1型受体(angiotensin Ⅱ type 1receptor,AT1R)抑制剂对人子宫内膜癌移植瘤的影响。方法选择6~8周龄的雌性裸鼠,注射人子宫内膜癌HEC-1B细胞悬液,建立人子宫内膜癌移植瘤模型后,随机平均分为肿瘤组和肿瘤抑制组。观察成瘤情况,并对瘤组织进行病理组织学检查,肿瘤微血管密度(microvessel density,MVD)和VEGF阳性率测定。结果细胞株被成功接种于裸鼠体内,裸鼠皮下移植瘤和AT1R抑制剂模型成功建立。两组模型中移植瘤的大小比较有明显差异(P<0.05),肿瘤组最大直径为11.34mm,最大体积为448.11mm3,平均体积210.56mm3;肿瘤抑制组最大直径9.01mm,最大体积216.46mm3,平均体积119.13mm3。两组移植瘤中MVD比较,肿瘤抑制组肿瘤间质血管明显减少(P<0.05)。两组移植瘤中VEGF表达情况比较,肿瘤抑制组阳性率显著低于肿瘤组(P<0.05)。结论 AT1R抑制剂能够明显抑制肿瘤组织间质内血管的生成,从而抑制肿瘤的生长和导致肿瘤组织的坏死,因此AT1R抑制剂在恶性肿瘤的治疗方面起着抑制肿瘤生长的作用。 Objective To explore angiotensinⅡtype 1 receptor(AT1R) inhibitor's influence on endometrial carcinoma transplanted tumor.Methods Female nude mouse aged 6 to 8 weeks were selected and were given endometrial carcinoma HEC-1B cell suspension.The endometrial carcinoma transplanted tumor model was randomly divided into tumor group and tumor suppression group,each had 6 cases.The tumor group was treated by normal saline.The tumor suppression group was treated by AT1R inhibitor.Tumor formation conditions were observed,pathological examination of transplanted tumor and tumor microvascular density(MVD) and positive incidence of vascular endothelial growth factor(VEGF) was measured.Results Cell strain was successfully inoculated,endometrial carcinoma transplanted tumor model and AT1R inhibitor model were successfully established.There was significant difference between the two groups in tumor size with P0.05.Tumor group: maximum diameter was 11.34 mm,the maximum volume was 448.11mm3,average volume was 210.56 mm3;tumor suppression group: maximum diameter was 9.01mm,the maximum volume was 216.46 mm3,average volume was 119.13 mm3.Tumor stroma blood vessels of tumor suppression group were significantly reduced with P0.05.Positive incidence of VEGF of tumor suppression group was significantly lower than it of tumor group with P0.05.Conclusion AT1R inhibitor can obviously inhibit the formation of tumor stroma blood vessels,lead to inhibition of the growth of tumors and tissue of tumour necrosis.Therefore AT1R inhibitor in malignant tumor treatment plays the role of inhibition of tumor growth.
出处 《中国实验诊断学》 2012年第12期2179-2182,共4页 Chinese Journal of Laboratory Diagnosis
关键词 裸鼠模型 AT1R抑制剂 子宫内膜癌 Nude mice model AngiotensinⅡtype 1 receptor Endometrial cancer
  • 相关文献

参考文献9

  • 1Weidner N,Intratumor microvessel density as a prognostic factor in eancer[J]. Am J Pathol,1995,147(1) :9.
  • 2罗营,糜若然.去势雌性裸小鼠人子宫内膜癌皮下移植瘤动物模型的建立[J].天津医科大学学报,2004,10(3):391-393. 被引量:6
  • 3Bauvois B. Transmembrane proteases in cell growth andinvasion: new contributors to angiogenesis[J]. Oncogene, 2004,23 : 317.
  • 4Deshayes F, Nahmias C. Angiotensin receptors: a now role in cancer[J].Trends Endoerinol Metab, 2005,16 : 293.
  • 5Egami K, Murohara T, Shimada T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth[J]. J Clin In vest, 2003,112 : 67.
  • 6Ino K, Shibata K, Kaiiyama H, et al. Manipulating the angiotensin system-new approaches to the treatment of solid tumours[J]. Ex-pert Opin Biol Ther,2006 ,6(3) :243.
  • 7Dinh DT, Frauman AG,Somers GR, et al. Evidence for activation 3f the rennin-angiotensin system in the human prostate:increased angiotensin II and reduced ATl-receptor expression in benign prostatic hyperplasia[J]. J pathol,2002,196(2) :213.
  • 8De paepe B,Verstraeten VL,de potter CR,et al. Growth stimula- tory angiotensis II type-1 receptor is up-regulated in breast hy- perplasia and in situ carcinoma but not in invasive carcinoma[J]. Histochem cell Biol,2001,116(3) : 247.
  • 9胡维维,陶金华,许欣,等.血管紧张素Ⅱ1型受体和血管紧张素转化酶在子宫内膜癌中的表达及相关性[J].临床实验与病理学杂志,2011,5.

二级参考文献11

  • 1Coullard S, Labrie C, Gauthier S, et al. Long - term inhibitory effect of the orally active and pure antiestrogen EM - 800 on the growth of human breast cancer xenografts in nude mice[J ]. Int J Cancer, 2000, 85:424
  • 2Jensen J, Kitlen JW, Briand P, et al. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF- 7 in serum- free medium[J]. J Steroid Biochem Mol Biol,2003 , 84(4): 469
  • 3Gutman M, Couillard S, Roy J, et al. Comparison of the effects of EM - 652 (SCH57068), tamoxifen, toremifene,droloxifene, idoxifene, GW - 5638 and raloxifene on the growth of human ZR-75- 1 breast tumors in nude mice[J] .Int J Cancer, 2002, 99(2): 273
  • 4Goss PE. Randomlized phase Ⅲ trial comparing the new potent and selective third- generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group[J ]. J Clin Oncol, 1999
  • 5Legro RS, Kunselman AR, Miller SA, et al. Role of androgens in the growth of endometrial carcinoma: an in vivo animal model[J ]. Am J Obstet Gynecol, 2001, 184(3): 303
  • 6Dardes RC, Schafer JM, Pearce ST, et al. Regulation of estrogen target genes and growth by selective estrogen - receptor modulators in endometrial cancer cells[J ]. Gynecol Oncol,2002,85(3):498
  • 7Sallot M, Lascombe L, Bermont L, et al. Comparision of the effect of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95- 2 cell[J] . Cancer Res,1997, 17:3 499
  • 8Takayama K.Treatment of severe postmenopausal endometriosis with an aromatase inhibitor[J] . Fertil Steril,1998, 69(4): 709
  • 9Kurebayashi J, Sonoo H, Inaji H , et al. Endocrine therapies for patients with recurrent breast cancer: predictive factors for responses to first- and second- line endocrine therapies [J]. Oncology, 2000, 59:131
  • 10郝光荣 姚明 朱德生.免疫缺陷动物[A].见:郝光荣主编.实验动物学[M].上海:第二军医大学出版社,2000.200-202.

共引文献5

同被引文献21

  • 1狄茂军,王卫星,兰明银,江斌,李恒,易建华.血管紧张素ⅡⅠ型受体在人肝细胞癌中的表达及意义[J].武汉大学学报(医学版),2005,26(2):235-237. 被引量:4
  • 2Fujimoto Y,Sasaki T,Tsuchida A,et al.Angiotensin Ⅱ type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin Ⅱ type 1 receptor antagonist[J].FEBS Left,2001,495(3):197-200.
  • 3Du N,Feng J,Hu LJ,et al.Angiotensin Ⅱ receptor type 1 blockers suppress the cell proliferation effects of angiotensin Ⅱ in breast cancer cells by inhibiting AT1R signaling[J].Oncol Rep,2012,27(6):1893-1903.
  • 4Uemura H,Ishiguro H,Nakaigawa N,et al.Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells:A possibility of tyrosine kinase inhibitor of growth factor[J].Mol Cancer Ther,2003,2 (11):1139-1147.
  • 5Chakra M,Pujol JL,Lamy PJ,et al.Circulating serum vascular endothelial growth factor is not a prognostic factor of non-sm all cell lung cancer[J].J Thorac Oncol,2008,3 (10):1119-1126.
  • 6H anrahan EO,Ryan AJ,Mann H,et al.Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-smallcell lung cancer[J].ClinCan Res,2009,15 (10):3600-3609.
  • 7Suganuma T,Ino K,Shibata K,et al.Functional expression of the angiotensin Ⅱ typel receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion,angiogenesis,and peritoneal dissemination[J].Clin Cancer Res,2005,11 (7):2686-2694.
  • 8Wilop S,von Hobe S,Crysandt M,et al.Impact of angiotensin Ⅰ converting enzyme inhibitors and angiotensin Ⅱ type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy[J].J Cancer Res Clin Oncol,2009,135 (10):1429-1435.
  • 9Nakai Y,Isayama H,Ijichi H,et al.Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine[J].Br J Cancer,2010,103 (11):1644-1648.
  • 10Yoshiji H,Noguchi R,Toyohara M,et al.Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma[J].J Hepatol,2009,51 (2):315-321.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部